Skip to content
  • Contacts
  • facebook
  • twitter
  • linkedin
registration | login

News and Events

The official online journal of the International Conference
on Thrombosis and Hemostasis Issues in Cancer
Recording available for the “Long-term treatment & DDI implications in the management of CAT” by ICTHIC Editorial Office 31 October 2022
Recording available for the webinar “Updates in Cancer-Associated Thrombosis” by ICTHIC Editorial Office 20 September 2022
Recording available for the webinar: What is the profile of the Real-World CAT patient? by ICTHIC Editorial Office 25 July 2022
Did you miss the 11th ICTHIC? Discover the highlights here by ICTHIC Editorial Office 15 July 2022
  • Home
  • Thrombosis and cancer
    • Epidemiology
    • Basic Mechanisms
    • Prevention
    • Trials and Therapy
    • Focus on: Atrial fibrillation
    • Focus on: Pediatrics
    • Focus on: COVID-19
  • Guidelines and Tools
  • Congress reports
    • ICTHIC 2022
    • ICTHIC 2021
    • ISTH 2020
    • ASH 2020
    • ASH 2019
    • ISTH 2019
    • ICTHIC 2018
    • ESC 2018
  • News and Events
  • Past webinars
  • About
  • Contacts
  • Editorial Board
  • Most Read
  • Podcast and videos
  • Archive
  • PARTNERSHIP
Webinar

Home › Thrombosis and cancer › Trials and Therapy › Page 2

Trials and Therapy

Is apixaban safe for primary VTE prevention in patients with gastrointestinal cancers? A summary of a post-hoc analysis of the AVERT trial

Patients with cancer and a Khorana score ≥2 have an estimated risk of symptomatic venous thromboembolism (VTE) of...
Author ICTHIC Editorial OfficePosted on 20 June 202114 July 2021

Investigating the drug−drug interactions occurring in cancer-associated thrombosis: use of checkpoint inhibitors and direct oral anticoagulants in a real-world setting

Advances in medicine and the possibility of keeping multiple diseases under control via medication have increased the...
Author ICTHIC Editorial OfficeAuthor Gary LymanAuthor Marc CarrierPosted on 10 December 202013 December 2020

The USCAT study: a retrospective non-interventional study to examine long-term treatment of CAT

Patients with cancer are at high risk of venous thromboembolism (VTE) recurrence and major bleeding (1). Most...
Author ICTHIC Editorial OfficeAuthor Charles FrancisAuthor Anna FalangaPosted on 26 November 202028 November 2020

The Art of Managing Cancer-Associated Thrombosis: Caravaggio and Beyond

Venous thromboembolism (VTE) is a frequent complication and the second leading cause of death in cancer patients....
Author Benjamin BrennerPosted on 23 July 20204 August 2020

Toward the replacement of low-molecular-weight heparins with the novel direct oral anticoagulants for the treatment of cancer-associated thrombosis

Value and limitations of low-molecular-weight heparins Following the demonstration that vitamin K antagonists (VKA) are...
Author Paolo PrandoniAuthor Elena CampelloPosted on 10 June 202022 June 2020

Incidental venous thromboembolism in cancer patients

It is well known that patients with cancer are at high risk of venous thromboembolism (VTE), especially when initiating...
Author Nick Van EsAuthor Frits MulderPosted on 30 April 20201 May 2020

Platelet Cut-Off for Anticoagulant Therapy in Thrombocytopenic Patients with Blood Cancer and Venous Thromboembolism

Venous thromboembolism (VTE) is a recurrent risk factor in cancer patients. In particular, patients with hematologic...
Author Anna FalangaAuthor Charles FrancisAuthor ICTHIC Editorial OfficePosted on 24 March 20202 April 2020

Isolated Distal DVT In Cancer Patients: What Do Recent Studies Suggest?

In a recent issue of the Journal of Thrombosis and Hemostasis, we report that cancer patients with isolated distal deep...
Author Alok KhoranaAuthor Shyam K PoudelPosted on 11 February 202012 February 2020

Direct oral anticoagulants for the treatment of cancer-associated thrombosis

Cancer-associated venous thromboembolism (VTE) is known to impact up to one-fifth of patients with cancer. The...
Author Alok KhoranaPosted on 26 September 201930 December 2019

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

The American Society of Clinical Oncology just published the new recommendations regarding VTE prophylaxis and...
Author ICTHIC Editorial OfficePosted on 20 August 201927 December 2019

Posts navigation

Previous page Page 1 Page 2 Page 3 Page 4 Next page

ICTHIC magazine is supported by the unrestricted educational grant from

SUBSCRIBE TO OUR NEWSLETTER

I agree to receive updates concerning the content published in ICTHIC MAGAZINE and related promotional content/activities (more details)

logo polistudium
Scientific and Web contents by Polistudium s.r.l.
Via Anfossi 36, 20135 Milan, Italy
info@polistudium.it
None of the information published on the ICTHC magazine website, in particular, information related to the choice and use of drugs, replaces the advice of a doctor
© COPYRIGHT 2019 ICTHIC Magazine
Privacy policy
None of the information published on the ICTHC magazine website, in particular, information related to the choice and use of drugs, replaces the advice of a doctor.

Accept to continue
By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC Magazine, in order to receive email messages concerning the content published in ICTHIC Magazine and related promotional content/activities. Your email address may also be added to this list as a result of signing up to this Website. Personal Data collected: email address, first name, last name, profession.
ICTHIC CONFERENCE Newsletter By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC, in order to receive newsletters concerning the conference, such as Save the date, information about the meeting venue, the publication of the program, registration fees and deadline, abstract submission deadline and oral communication/poster instructions, hotel booking availability and deadline, social program for accompanying persons, the publication of speakers slides, photo/videogallery of the last edition and information about future editions of the conference. Your email address may also be added to this list as a result of signing up to this Website.